We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.13B
AUM Growth
+$72.2M
Cap. Flow
+$9.62M
Cap. Flow %
0.85%
Top 10 Hldgs %
7.17%
Holding
858
New
204
Increased
192
Reduced
260
Closed
148

Top Buys

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$4.82M
2
VFC icon
VF Corp
VFC
+$4.71M
3
INSP icon
Inspire Medical Systems
INSP
+$4.06M
4
GLW icon
Corning
GLW
+$3.96M
5
PCRX icon
Pacira BioSciences
PCRX
+$3.94M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$7.22M
2
UBER icon
Uber
UBER
+$5.67M
3
TEAM icon
Atlassian
TEAM
+$5.66M
4
HOOD icon
Robinhood
HOOD
+$5.36M
5
NTLA icon
Intellia Therapeutics
NTLA
+$4.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.98%
2 Technology 20.39%
3 Industrials 14.03%
4 Consumer Discretionary 11.34%
5 Financials 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YOU icon
26
Clear Secure
YOU
$5.26B
$5.01M 0.44%
151,172
-68,782
-31% -$1.77M
PODD icon
27
Insulet
PODD
$11.3B
$5M 0.44%
21,492
-10,800
-33% -$2.22M
WMB icon
28
Williams Companies
WMB
$90.5B
$5M 0.44%
+109,577
New +$4.82M
FTI icon
29
TechnipFMC
FTI
$30.6B
$4.95M 0.44%
188,899
+41
+0% +$1.09K
INSP icon
30
Inspire Medical Systems
INSP
$1.42B
$4.94M 0.44%
+23,387
New +$4.06M
VRN
31
DELISTED
Veren
VRN
$4.89M 0.43%
795,255
+448,826
+130% +$3.21M
SRPT icon
32
Sarepta Therapeutics
SRPT
$1.66B
$4.87M 0.43%
39,024
+3,795
+11% +$525K
RKT icon
33
Rocket Companies
RKT
$36.9B
$4.87M 0.43%
253,936
+143,664
+130% +$2.52M
LPX icon
34
Louisiana-Pacific
LPX
$5.2B
$4.76M 0.42%
44,339
QGEN icon
35
Qiagen
QGEN
$8.53B
$4.76M 0.42%
101,523
+44,186
+77% +$2.01M
ROIV icon
36
Roivant Sciences
ROIV
$25.2B
$4.61M 0.41%
399,107
+215,000
+117% +$2.45M
T icon
37
AT&T
T
$165B
$4.6M 0.41%
208,900
-20
-0% -$398
CAH icon
38
Cardinal Health
CAH
$53.4B
$4.55M 0.4%
41,200
-5,600
-12% -$586K
MIRM icon
39
Mirum Pharmaceuticals
MIRM
$6.89B
$4.43M 0.39%
113,712
+74,349
+189% +$2.97M
DVA icon
40
DaVita
DVA
$15.1B
$4.41M 0.39%
26,887
+5,506
+26% +$813K
CTAS icon
41
Cintas
CTAS
$82.4B
$4.41M 0.39%
21,400
-9,668
-31% -$1.87M
XYZ
42
Block Inc
XYZ
$45.9B
$4.36M 0.39%
64,964
-8,216
-11% -$531K
LRCX icon
43
Lam Research
LRCX
$382B
$4.33M 0.38%
53,010
-990
-2% -$86.1K
NTRA icon
44
Natera
NTRA
$37.5B
$4.32M 0.38%
34,032
+29,253
+612% +$3.36M
GT icon
45
Goodyear
GT
$2.07B
$4.32M 0.38%
487,694
+361,230
+286% +$3.41M
CVLT icon
46
Commault Systems
CVLT
$5.89B
$4.27M 0.38%
27,777
GLW icon
47
Corning
GLW
$126B
$4.25M 0.38%
+94,126
New +$3.96M
CLS icon
48
Celestica
CLS
$35.1B
$4.22M 0.37%
82,602
+21,874
+36% +$1.13M
APLS
49
DELISTED
Apellis Pharmaceuticals
APLS
$4.2M 0.37%
145,519
+52,663
+57% +$1.95M
MGY icon
50
Magnolia Oil & Gas
MGY
$5.83B
$4.19M 0.37%
171,493
-86,497
-34% -$2.18M

Similar funds

PDT Partners's Q3 2024 Portfolio in Review

As of Q3 2024, PDT Partners held 858 positions worth $1.13B, up 6.8% from $1.06B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

PDT Partners's Q3 2024 filing shows 204 new, 192 increased, 260 reduced and 148 closed positions. Its largest new stake was Williams Companies: 109,577 shares worth $5M. The largest sale was Spotify, an estimated $7.22M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • PDT Partners's largest Q3 2024 buy was Williams Companies: 109,577 shares worth $5M.
  • PDT Partners added most to e.l.f. Beauty in Q3 2024, an estimated $3.84M increase.
  • PDT Partners's biggest Q3 2024 reduction was Spotify, cutting an estimated $7.22M.
  • PDT Partners fully exited Atlassian in Q3 2024, selling an estimated $5.66M.
  • PDT Partners's ten largest holdings make up 7.2% of its $1.13B portfolio in Q3 2024.
  • PDT Partners opened 204 new positions and closed 148 in Q3 2024.
  • PDT Partners's portfolio value rose 6.8% quarter-over-quarter to $1.13B.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.